1Schtlttler J , lhnmen H. Population pharmacokinetics of propfol: a multlcenter study. Aneathesiology, 2000,92: 727-738.
2Schnider TW, Minto CF, Gambus PL, et al.The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology, 1998,88:1170- 1182.
3Mazoit JX, Samii K. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol,1999,47 : 35-42.
4Labroo RB, Paine MF, Thummel KE.Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in dusoisution, efficacy, and drug interactions. Drug Metab Diapos, 1997,25:1072-1080.
5Gitton J, Bumnfeese T, Desage M. Possible involvement of multiple human cytochrpme P450 isoforms in the liver metabolism of propofol.Br J Anaesth, 1998,80: 788-795.
6Odo Y, Hamaoka N, Hirio T, et al. Involvement of human fiver cytochrome P450 2B6 in the metabolism of propofol.Br J Clin Pharmacol,2001,51:281-285.
7Miller E,Park GR.The effect of oxygen on propofol-induced inhibition of microsomal cytochrome P450 3A4. Anaesthesia, 1999, 54:320-322.
8Tackley RM, Lewis GTR, Roberts CP, et al. Computer controlled infusion of propofol. Br J Anaesth, 1989,62 : 46-53.
6Kiiru Y, Kmedliro D, Fzmer K, et al. Evolution of endovaseular therapy for aneurysm treatment:historical overview [J]. Neurosurg Focus ,2005,15,18(2) :E2.
7Barakat A R, Sutcliffe N, Schwab M. Effect site concentration during propofol TCI sedation : a comparison of sedation score with two pharmacokinetic models [J]. Anesthesia, 2007,62 (7) : 661-666.
8Drover D R, Lemmens H J. Population pharmaeokinetics and pharmacodynamics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery[J]. Anesthesiology, 1998, 89(4) :869-877.
